Document is current
Any future updates will be listed below
-
Authors
Manrique-Saide, Pablo
Dean, Natalie E.
Halloran, M. Elizabeth
Longini, Ira M.
Collins, Matthew H.
Waller, Lance A.
Gomez-Dantes, Hector
Lenhart, Audrey
Hladish, Thomas J.
Che-Mendoza, Azael
Kirstein, Oscar D.
Romer, Yamila
Correa-Morales, Fabian
Palacio-Vargas, Jorge
Mendez-Vales, Rosa
Pérez, Pilar Granja
Pavia-Ruz, Norma
Ayora-Talavera, Guadalupe
Vazquez-Prokopec, Gonzalo M. https://orcid.org/0000-0002-0710-270X
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01AI148069)
National Institute of Allergy and Infectious Diseases (R01 AI139761)
National Institutes of Health (U54 GM111274)
National Institutes of Health (R37 AI0032042)
Innovative Vector Control Consortium (DFID:30041-105)
- License Information
-
More Information
Article History
Received: 23 July 2020
Accepted: 29 September 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: This trial protocol has been approved by Emory University (IRB00108666) and the Autonomous University of Yucatan (CEI-05-2020) and endorsed by the Secretarias de Salud de Yucatan. Written consent/assent will be obtained from participants and kept in a secure place for record-keeping and trial monitor evaluation.
: The authors declare that they have no competing interests.
